Shu-Chih Chen
Oprichter bij ATOSSA THERAPEUTICS, INC.
Vermogen: - $ op 30-06-2024
Actieve functies van Shu-Chih Chen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-04-2009 | - |
| Oprichter | 01-12-2008 | - | |
| Hoofd Techniek/Wetenschap/O&O | 01-04-2010 | - |
Loopbaan van Shu-Chih Chen
Eerdere bekende functies van Shu-Chih Chen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SC2Q Consulting Co. | Oprichter | 01-01-2006 | 01-01-2008 |
| President | - | 01-01-2008 | |
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Directeur/Bestuurslid | 01-01-2002 | 01-01-2006 |
| Ensisheim Partners LLC | President | 01-01-2008 | - |
| National Yang Ming University | Corporate Officer/Principal | - | - |
Opleiding van Shu-Chih Chen
| Michigan State University | Doctorate Degree |
| National Yang Ming University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Taiwan | 2 |
Operationeel
| Director/Board Member | 2 |
| Founder | 2 |
| President | 2 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| SC2Q Consulting Co. | |
| Ensisheim Partners LLC | |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
- Beurs
- Insiders
- Shu-Chih Chen
- Ervaring
